Space Medicine Market

Medical devices are estimated to hold 31.0% by product type in 2026 while telemedicine solutions capture 35.0% and regenerative medicine represents 29.0%. Adoption depends on flight-qualified care systems that retain clinical performance under radiation and communication delay, but mission testing slows commercial entry.